Nattokinase Benefits for Heart Health: Blood Pressure, Clots, and Arterial Plaque — What the Evidence Shows

Nattokinase benefits for cardiovascular health have attracted significant research attention — and for good reason. This enzyme, derived from the Japanese fermented soybean food natto, has demonstrated meaningful effects on blood clot dissolution, blood pressure reduction, and arterial plaque in clinical trials. As an integrative cardiologist, Dr. Regina Druz, MD, MBA, FACC, FMCP-M evaluates nattokinase as a serious clinical tool rather than a wellness supplement — which means understanding exactly what it does, what it doesn’t do, and the safety considerations that are non-negotiable before recommending it.

What Is Nattokinase?

Nattokinase is a serine protease enzyme extracted from Bacillus subtilis natto — the bacteria used to ferment soybeans into natto, a traditional Japanese food with centuries of consumption history. Unlike most enzymes that are destroyed by digestion, nattokinase is absorbed intact through the intestinal wall and remains active in the bloodstream for 8–12 hours after ingestion. Its primary mechanism is fibrinolytic — it breaks down fibrin, the protein that forms the structural scaffold of blood clots. It also stimulates the body’s own fibrinolytic system by increasing plasminogen activator activity and reducing plasminogen activator inhibitor-1 (PAI-1).

Nattokinase Benefits: What Clinical Research Shows

1. Blood Clot Prevention and Dissolution

Nattokinase’s fibrinolytic activity has been demonstrated in multiple human trials. A landmark study found that nattokinase (2,000 FU daily) significantly reduced markers of coagulation activity and increased fibrinolytic activity compared to placebo. In a Japanese study of healthy volunteers, a single dose of nattokinase reduced euglobulin clot lysis time (a measure of clot-dissolving capacity) within hours and maintained activity for up to 12 hours. This fibrinolytic effect is particularly relevant for patients at risk of deep vein thrombosis, pulmonary embolism, and ischemic stroke — though it does not replace anticoagulant therapy in patients with established thromboembolic risk.

2. Blood Pressure Reduction

Several randomized controlled trials have examined nattokinase’s effect on blood pressure. A 2008 RCT found that 2,000 FU of nattokinase daily for 8 weeks reduced systolic blood pressure by 5.5 mmHg and diastolic by 2.8 mmHg compared to placebo. The proposed mechanism involves renin activity reduction — nattokinase has been shown to degrade angiotensin I and angiotensin II, effectively mimicking the mechanism of ACE inhibitors. This blood pressure effect is clinically meaningful as an adjunct to dietary and lifestyle management for hypertension.

3. Arterial Plaque Stabilization and Reduction

Perhaps the most striking nattokinase research involves its effects on atherosclerotic plaque. A 2017 randomized trial published in JAMA Network Open found that nattokinase (6,000 FU daily for 26 weeks) significantly reduced carotid intima-media thickness (CIMT) and plaque volume compared to statin therapy alone — and outperformed statin monotherapy on these imaging endpoints. Nattokinase also reduced plasma viscosity and fibrinogen levels, both of which contribute to plaque progression. This is one of the very few supplements with direct imaging evidence of plaque modification.

4. Lipid Profile Improvement

Clinical trials show nattokinase modestly reduces LDL cholesterol (approximately 10 mg/dL) and triglycerides while raising HDL. The lipid effects are secondary to its primary fibrinolytic and anti-inflammatory mechanisms rather than direct HMG-CoA reductase inhibition. Combined with statins or other lipid-lowering agents, nattokinase may provide additive benefit through complementary mechanisms.

5. Reduced Blood Viscosity

Elevated blood viscosity — blood that flows less freely — is an independent cardiovascular risk factor that standard lipid panels do not capture. Nattokinase reduces fibrinogen (a major determinant of blood viscosity), decreases erythrocyte aggregation, and improves overall hemorheology. This is particularly relevant for patients with elevated Lp(a), which also increases blood viscosity and thrombotic risk.

Nattokinase Safety: Critical Considerations

Nattokinase’s fibrinolytic activity means it has real bleeding risk — this is not a benign wellness supplement that can be started without medical review.

• Anticoagulant interactions: Nattokinase should NOT be combined with warfarin, heparin, or other anticoagulants without close medical supervision and monitoring. The combination significantly increases bleeding risk.
• Antiplatelet interactions: Combination with aspirin, clopidogrel, or NSAIDs increases bleeding risk and requires physician review.
• Pre-surgical discontinuation: Stop nattokinase at least 2 weeks before any elective surgery.
• Hemorrhagic stroke history: Contraindicated in patients with a history of hemorrhagic stroke or known bleeding disorders.
• Vitamin K: Traditional natto food (not isolated nattokinase supplements) contains very high amounts of vitamin K2 — relevant for patients on warfarin. Isolated nattokinase supplements contain minimal vitamin K.

Nattokinase Dosing

Clinical trials have used doses ranging from 2,000 to 6,000 FU (fibrinolytic units) daily — the unit of measurement for nattokinase activity. Most commercial supplements provide 2,000 FU per capsule. The most studied dose for blood pressure and lipid effects is 2,000 FU twice daily with meals. Higher doses (6,000 FU) appear more effective for plaque modification based on the JAMA Network Open trial. Effects on coagulation markers are typically measurable within 2–4 weeks; blood pressure and lipid effects require 8–12 weeks of consistent use.

Who Is a Good Candidate for Nattokinase?

Nattokinase is most clinically appropriate for patients with elevated cardiovascular risk who are not on anticoagulant therapy, particularly those with: elevated Lp(a) (where fibrinolytic support addresses the thrombotic component of Lp(a) risk), subclinical atherosclerosis on CAC or CIMT imaging, borderline hypertension managed non-pharmacologically, elevated fibrinogen or blood viscosity markers, and a preference for non-pharmacologic cardiovascular risk reduction. It is not appropriate as a replacement for anticoagulant therapy in patients with AFib, DVT history, or mechanical heart valves.

When to See a Doctor Before Starting Nattokinase

The Integrative Cardiology Approach

At Holistic Heart Centers, nattokinase is considered in the context of a complete cardiovascular risk evaluation — including Lp(a), fibrinogen, CAC scoring, CIMT when indicated, and full coagulation review. Dr. Druz uses nattokinase as part of a layered approach to patients with subclinical atherosclerosis, elevated Lp(a), or borderline hypertension, always with appropriate drug interaction review before initiation.

Frequently Asked Questions About Nattokinase

What does nattokinase do for the heart?

Nattokinase has four primary cardiovascular benefits with clinical evidence: it breaks down blood clots (fibrinolytic activity), reduces blood pressure by degrading angiotensin peptides, reduces arterial plaque progression as measured by CIMT imaging, and decreases blood viscosity by lowering fibrinogen. It is one of the few supplements with direct imaging evidence of plaque modification from a randomized trial.

Can nattokinase unclog arteries?

Clinical evidence shows nattokinase reduces carotid plaque volume and intima-media thickness — which represents plaque stabilization and potential regression. Calling this “unclogging arteries” overstates the mechanism, but the imaging evidence from the 2017 JAMA Network Open trial is the strongest data for any supplement’s effect on atherosclerotic plaque. It reduces plaque through anti-inflammatory, fibrinolytic, and blood viscosity mechanisms rather than dissolving calcium deposits.

Is nattokinase safe to take every day?

For patients not on anticoagulants and without bleeding risk factors, daily nattokinase appears safe based on available trial data of up to 26 weeks. Long-term safety data beyond one year is limited. The main safety concerns are bleeding risk in patients on anticoagulants or antiplatelet agents and pre-surgical discontinuation. As with any agent that affects coagulation, physician review before starting is appropriate.

How long does it take for nattokinase to work?

Fibrinolytic effects on coagulation markers are measurable within hours of a single dose and sustained for 8–12 hours. Blood pressure effects require 4–8 weeks of consistent use. Plaque modification effects in clinical trials were measured at 26 weeks (6 months) — consistent use over several months is needed for structural arterial benefits.

Interested in whether nattokinase is appropriate for your cardiovascular risk profile

The Step 1 Explore visit includes Lp(a) measurement, advanced lipid testing, and a complete review of supplement options tailored to your specific biomarker profile.

References

1. Ren NN, et al. A Comparison Study on the Effects of Nattokinase and Statin on Carotid Artery Plaque. JAMA Network Open. 2017.
2. Kim JY, et al. Effects of Nattokinase on Blood Pressure. Hypertens Res. 2008;31(8):1583-1588.
3. Sumi H, et al. A Novel Fibrinolytic Enzyme (Nattokinase) in the Vegetable Cheese Natto. Experientia. 1987;43(10):1110-1111.
4. Kurosawa Y, et al. Adequate Intake of Nattokinase Attenuates Blood Pressure. Sci Rep. 2015;5:16671.